Priority Meds vs ReadyRx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Priority Meds
Best for pending product verificationStarting at $113/mo
ReadyRx
Best for compounded GLP-1 buyers who want LegitScript certification and explicit batch lab testing claims at a sub-$200 starting priceStarting at $179/mo
Side-by-Side Comparison
| Feature | Priority Meds | ReadyRx |
|---|---|---|
| Overall Score | 7.1/10 | ✓7.2/10 |
| Starting Price | ✓$113/mo | $179/mo |
| Editorial Rating | 3.6 ★ /5 | 3.6 ★ /5 |
| Features | 4 features | ✓5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Priority Meds
Pros
- ✓Flat-dose pricing (no dose-escalation increases) per competitor sources
- ✓B-vitamin co-compounding (sema+B12, tirz+B6) is a differentiator in the segment
- ✓Clearwater FL based US operation
Cons
- ✗Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
ReadyRx
Pros
- ✓LegitScript certified — directly verifiable via the badge link in the footer
- ✓Batch lab testing claim covers four standard QA categories (potency, sterility, pH, endotoxicity) — these are the right metrics for compounded injectables
- ✓Pricing publicly displayed: $179/mo semaglutide, $255/mo tirzepatide
Cons
- ✗Specific FDA-registered pharmacy partner names are not disclosed publicly — claim is generic ('FDA-registered compounding pharmacies')
- ✗Clinical staff are described as 'Licensed, board-certified clinicians' but no individual NPIs or names are published on the homepage
- ✗5,000+ member figure is sourced from a competitor directory, not independently audited
Our Verdict
ReadyRx edges out Priority Meds with a higher overall score of 7.2/10 and is particularly strong for compounded GLP-1 buyers who want LegitScript certification and explicit batch lab testing claims at a sub-$200 starting price. Priority Meds remains a solid alternative, especially if you're looking for pending product verification.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.